LI-RADS v2018 versus KLCA-NCC v2022: comparison of probability-based HCC categories - Summary - MDSpire

LI-RADS v2018 versus KLCA-NCC v2022: comparison of probability-based HCC categories

  • By

  • Jeong Hee Yoon

  • Eun Sun Lee

  • Young Kon Kim

  • Chang Hee Lee

  • Jeong Woo Kim

  • Won Chang

  • Joon-Il Choi

  • Beom Jin Park

  • Jin-Young Choi

  • Seung-seob Kim

  • Jeong-Sik Yu

  • Seong Jin Park

  • Myung-Won You

  • Myoung-jin Jang

  • Hee Sun Park

  • Jeong Min Lee

  • June 26, 2026

  • 0 min

Share

Objective:

To compare the probability of hepatocellular carcinoma (HCC) across corresponding categories of LI-RADS v2018 and KLCA-NCC v2022.

Approach:
  • Study Design: A retrospective multicenter study involving eleven tertiary hospitals in South Korea.
  • Eligibility Criteria: Included HCC-naïve patients with chronic hepatitis B or C, or cirrhosis, who underwent gadoxetic acid-enhanced MRI.
  • Image Acquisition: MRI and CT scans were performed using standard protocols with specific imaging sequences.
  • Image Analysis: Four radiologists independently reviewed tumors and assigned LI-RADS and KLCA-NCC categories.
  • Statistical Analysis: Diagnostic performance was assessed using generalized estimating equations (GEE) and interobserver agreement was evaluated.
Key Findings:
  • LI-RADS v2018 and KLCA-NCC v2022 categorize HCC probability using different major features and ancillary features.
  • Both systems include categories for definite HCC, probable HCC, and indeterminate nodules.
  • Limited evidence exists supporting the equivalence of categories between the two systems due to distinct diagnostic criteria.
Interpretation:

Limitations:
  • The study is retrospective and may be subject to selection bias.
  • The diagnostic criteria for LI-RADS and KLCA-NCC differ, complicating direct comparisons.
Conclusion:

Original Source(s)

Related Content